Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Pharmacogenomics
 More »

  • Multitasking Multiplex Assays
    ... FDA approval is expected in 2014. A variety of multiplex assays can be performed on the platform, including pharmacogenomics tests for warfarin and Plavix sensitivity, a test for ...
    10-15-2013
  • 10 Reasons the Human Genome Matters in Medicine
    ... The Mayo Clinic hosted conference will focus on practical applications for integrating genomics and pharmacogenomics to individualize patient care, strategies to overcome obstacles ...
    9-12-2013
  • Big Need in IBD: Drugs to Slow Progression
    ... The committee was formed to provide insights into the potential for cardiovascular risks, based upon concerns with a similar drug developed by a competing company. Pharmacogenomics ...
    8-1-2013
  • Harnessing the Clinical Power of Single Cells
    ... Kumar, the technology is also nondestructive: "Essentially unaltered cells can be isolated for additional analysis, for example, using RT-PCR." He points to pharmacogenomics as an ...
    6-21-2013
  • Denovo Partners with ALS Nonprofit to ID Biomarkers
    The ALS Emergency Treatment Fund (ALS-ETF) and Denovo Biomarkers are partnering in a pharmacogenomics-based effort to identify potential responder groups for drugs being studied in ...
    5-10-2013
  • Pricing Out Prescription Genomic Medicine
    ... Predictive Modeling Today, predictive modeling is commonplace for understanding everything from presidential elections to the weather. 29-32 Predictive modeling in pharmacogenomics ...
    3-1-2013
  • DNA Sequencing: The Clinical Potential
    This work brought to the table a host of "omics"-pharmacogenomics, pharmacogenetics, proteomics, and metabolomics-all of which are supposed to play a part in companion diagnostics ...
    1-15-2013
  • NIDA Refocuses on Translational, Genetic Medicine
    in terms of smoking cessation, pharmacogenomics, treatment of substance abuse, and ... They include protein capture reagents, proteomics, genomics, pharmacogenomics, molecular ...
    12-6-2012
  • Chemotherapy for the 21st Century
    ... director of the Institute for Pharmacogenomics & Individualized Therapy and the Fred Eshelman Distinguished Professor of Pharmacogenomics and Individualized Therapy at the ...
    10-30-2012
  • CLC Bio Wins $2M For Pathogen Sequencing
    and influenza A. The consortium will in addition be investigating two host cell pharmacogenomics biomarkers that predict response to therapy for HCV and HIV. Bioinformatics ...
    8-30-2012
  • Mutation Test for Pancreatic Cancer Wins NIH Funding
    automated high-sensitivity genetic variation and mutation analysis, including discovery and laboratory testing services in the fields of pharmacogenomics and personalized medicine. ...
    8-22-2012
  • Predicting The Future During Drug Development
    ... hypothesis-generating work with pharmacogenomics, proteomics and similar types of tools. ... Pharmacogenomics The ability to identify patients with a high likelihood of treatment ...
    8-21-2012
  • Race-based Medicine: Reality or an Illusion?
    Indeed, since the advent of pharmacogenomics and the FDA's decision two years ago to approve BiDil for use by black Americans suffering from heart failure, the term "race-based ...
    8-10-2012
  • Harnessing the Promise of Array CGH
    ... was discovered, its role in biomedical areas as diverse as physiological development, disease pathogenesis, pharmacogenomics, and evolution has become increasingly apparent. ...
    8-1-2012
  • OGT Awarded $3.6M for Next-Generation Sequencing
    B (HBV) and C (HCV), and influenza A. PATHSEEK will also investigate two host pharmacogenomics biomarkers which predict response to therapy for HCV and HIV. OGT have the rights ...
    7-24-2012
  • More »

    Journal Articles

  • The Canadian Pharmacogenomics Network for Drug Safety: A Model...
    Colin J.D. Ross, Henk Visscher, Johanna Sistonen, Liam R. Brunham, Kusala Pussegoda, Tenneille T. Loo, Michael J. Rieder, Gideon Koren, Bruce C. Carleton, Michael R. Hayden
    Thyroid
    The Canadian Pharmacogenomics Network for Drug Safety: A Model for Safety Pharmacology ... Pharmacogenomics research seeks to identify genetic factors that are responsible for ...
  • Pharmacogenomics: Its Role in Re-establishing Coumarin as Treatment...
    Nicholas Farinola, Neil Piller
    Lymphatic Research and Biology
    Pharmacogenomics: Its Role in Re-establishing Coumarin as Treatment for Lymphedema ... The use of pharmacogenomics could significantly lower the risk of coumarin-associated ...
  • Pharmacogenomics Variation in Drug Metabolizing Enzymes and Transporte...
    Zainab Awada, Syed Haider, Arafat Tfayli, Ali Bazarbachi, Nagi El Saghir, Ziad Salem, Ali Shamseddine, Ali Taher, Nathalie Khoueiry Zgheib
    OMICS: A Journal of Integrative Biology
    Pharmacogenomics Variation in Drug Metabolizing Enzymes and Transporters in Relation to ... cancer impacting LMICs, we suggest pharmacogenomics is considered as an integral part of ...
  • From Pharmacogenomics to Improved Patient Outcomes: Angiotensin...
    David W. Moskowitz
    Diabetes Technology & Therapeutics
    From Pharmacogenomics to Improved Patient Outcomes: Angiotensin I-Converting Enzyme as an ... This experience suggests the power of pharmacogenomics to improve clinical outcomes for ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll